Literature DB >> 34812730

Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.

Michael P Kolinsky1, Karen Y Niederhoffer2, Edmond M Kwan3, Sebastien J Hotte4, Zineb Hamilou5, Steven M Yip6, Kim N Chi7, Alexander W Wyatt8, Fred Saad9.   

Abstract

Entities:  

Year:  2022        PMID： 34812730      PMCID： PMC9054340          DOI： 10.5489/cuaj.7621

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   2.052


× No keyword cloud information.
  64 in total

1.  Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.

Authors:  S Paluch-Shimon; F Cardoso; C Sessa; J Balmana; M J Cardoso; F Gilbert; E Senkus
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

2.  Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.

Authors:  Wassim Abida; Joshua Armenia; Anuradha Gopalan; Ryan Brennan; Michael Walsh; David Barron; Daniel Danila; Dana Rathkopf; Michael Morris; Susan Slovin; Brigit McLaughlin; Kristen Curtis; David M Hyman; Jeremy C Durack; Stephen B Solomon; Maria E Arcila; Ahmet Zehir; Aijazuddin Syed; Jianjiong Gao; Debyani Chakravarty; Hebert Alberto Vargas; Mark E Robson; Vijai Joseph; Kenneth Offit; Mark T A Donoghue; Adam A Abeshouse; Ritika Kundra; Zachary J Heins; Alexander V Penson; Christopher Harris; Barry S Taylor; Marc Ladanyi; Diana Mandelker; Liying Zhang; Victor E Reuter; Philip W Kantoff; David B Solit; Michael F Berger; Charles L Sawyers; Nikolaus Schultz; Howard I Scher
Journal:  JCO Precis Oncol       Date:  2017-05-31

3.  Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

Authors:  Johann Sebastian de Bono; Stephane Oudard; Mustafa Ozguroglu; Steinbjørn Hansen; Jean-Pascal Machiels; Ivo Kocak; Gwenaëlle Gravis; Istvan Bodrogi; Mary J Mackenzie; Liji Shen; Martin Roessner; Sunil Gupta; A Oliver Sartor
Journal:  Lancet       Date:  2010-10-02       Impact factor: 79.321

4.  Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.

Authors:  Daniel L Suzman; Brandon Luber; Michael T Schweizer; Rosa Nadal; Emmanuel S Antonarakis
Journal:  Prostate       Date:  2014-07-22       Impact factor: 4.104

5.  Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.

Authors:  Tahlia Scheinberg; Annabel Goodwin; Emilia Ip; Anthony Linton; Blossom Mak; David P Smith; Martin R Stockler; Madeleine C Strach; Ben Tran; Alison L Young; Alison Y Zhang; Kate L Mahon; Lisa G Horvath
Journal:  JCO Oncol Pract       Date:  2020-09-24

6.  Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.

Authors:  Haitham W Tuffaha; Andrew Mitchell; Robyn L Ward; Luke Connelly; James R G Butler; Sarah Norris; Paul A Scuffham
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

7.  Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.

Authors:  Alexander W Wyatt; Matti Annala; Rahul Aggarwal; Kevin Beja; Felix Feng; Jack Youngren; Adam Foye; Paul Lloyd; Matti Nykter; Tomasz M Beer; Joshi J Alumkal; George V Thomas; Robert E Reiter; Matthew B Rettig; Christopher P Evans; Allen C Gao; Kim N Chi; Eric J Small; Martin E Gleave
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

8.  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Authors:  Colin C Pritchard; Joaquin Mateo; Michael F Walsh; Navonil De Sarkar; Wassim Abida; Himisha Beltran; Andrea Garofalo; Roman Gulati; Suzanne Carreira; Rosalind Eeles; Olivier Elemento; Mark A Rubin; Dan Robinson; Robert Lonigro; Maha Hussain; Arul Chinnaiyan; Jake Vinson; Julie Filipenko; Levi Garraway; Mary-Ellen Taplin; Saud AlDubayan; G Celine Han; Mallory Beightol; Colm Morrissey; Belinda Nghiem; Heather H Cheng; Bruce Montgomery; Tom Walsh; Silvia Casadei; Michael Berger; Liying Zhang; Ahmet Zehir; Joseph Vijai; Howard I Scher; Charles Sawyers; Nikolaus Schultz; Philip W Kantoff; David Solit; Mark Robson; Eliezer M Van Allen; Kenneth Offit; Johann de Bono; Peter S Nelson
Journal:  N Engl J Med       Date:  2016-07-06       Impact factor: 91.245

9.  Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference.

Authors:  Kendal Jensen; Eric Q Konnick; Michael T Schweizer; Alexandra O Sokolova; Petros Grivas; Heather H Cheng; Nola M Klemfuss; Mallory Beightol; Evan Y Yu; Peter S Nelson; Bruce Montgomery; Colin C Pritchard
Journal:  JAMA Oncol       Date:  2021-01-01       Impact factor: 31.777
View more
  1 in total

1.  Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.

Authors:  Hiroko Kimura; Kei Mizuno; Masaki Shiota; Shintaro Narita; Naoki Terada; Naohiro Fujimoto; Keiji Ogura; Shotaro Hatano; Yusuke Iwasaki; Nozomi Hakozaki; Satoshi Ishitoya; Takayuki Sumiyoshi; Takayuki Goto; Takashi Kobayashi; Hidewaki Nakagawa; Toshiyuki Kamoto; Masatoshi Eto; Tomonori Habuchi; Osamu Ogawa; Yukihide Momozawa; Shusuke Akamatsu
Journal:  Br J Cancer       Date:  2022-08-19       Impact factor: 9.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.